LUNG STOCK ANALYSIS
Price summary
Last Close
1.39 $
Jul 2, 26
Market Cap
58.2 M $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%-48.9
Volatility
%98.6
Sharpe Ratio
-0.57
Sortino Ratio
-0.60
Distance to Peak
%-63.2
Maximum Drawdown
-%69.0
Seasonality
Seasonality Chart
Periodic Returns
1M
-13.7%
3M
+4.5%
6M
-37.1%
YTD
-37.1%
1Y
-48.9%
3Y
-89.3%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current Pulmonx Corp (LUNG) stock price?
LUNG last closed at 1.39 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the market capitalization of Pulmonx Corp?
Pulmonx Corp (LUNG) has a market capitalization of approximately 58.2 M $ as of the latest reported period.
Who are the main competitors of LUNG?
Key peers of Pulmonx Corp include Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi, Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi, Smith & Nephew PLC, 4DMEDICAL Ltd. A detailed metric comparison is available on the Peers tab.
Go deeper on LUNG
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
